Get the SPI Wire

Silexion Therapeutics Corp

NASDAQ:SLXN
Annual Meeting

of Shareholders

MEETING DATE

09/09/2026
DEF 14A FILED
08/24/2026
PUBLISHED
08/25/2026 12:36 pm
TIME TO PUBLISH
08/27/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:SLXN · CUSIP G1281K130 · CLASS ordinary shares · CIK 0002022416

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

2
FOR
0
AGAINST
0
WITHHOLD
2
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
Authorized Share Capital Increase Proposal
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the increase is needed to maintain Nasdaq shareholders' equity compliance and support financing needs.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
Reverse Share Split Proposal
other
Routine
For
Board FOR · Duopoly unknown — No divergence flagged

Filing states the reverse split is intended to maintain compliance with Nasdaq's $1.00 minimum bid price requirement.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

3e6ec8a70380d0b93a16bbea7c32937f4fd4be0ec1d9c6dee0560b9539a5a3ec

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates